Canaccord lowered the firm’s price target on Quantum-Si (QSI) to $1 from $1.50 and keeps a Hold rating on the shares. The firm noted the announced 3Q24 results and provided a business update. Placements of QSI’s Platinum protein sequencer were modestly below our expectations.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QSI: